Literature DB >> 33830449

Ellagitannins from Rosa roxburghii suppress poly(I:C)-induced IL-8 production in human keratinocytes.

Satoru Takayama1,2, Miho Kawanishi3, Kosei Yamauchi3, Daiki Tokumitsu4, Hiroyuki Kojima5, Teruaki Masutani5, Arunasiri Iddamalgoda5, Tohru Mitsunaga3, Hiroyuki Tanaka6,7.   

Abstract

The anti-inflammatory effects of a 50% aqueous extract of Rosa roxburghii fruit (RRFE) and two ellagitannins (strictinin and casuarictin) isolated from the RRFE were evaluated in a cell model of skin inflammation induced by self-RNA released from epidermal cells damaged by UV ray (UVR) irradiation. The RRFE inhibited interleukin-8 (IL-8) mRNA expression in normal human epidermal keratinocytes (NHEKs) stimulated with polyinosinic:polycytidylic acid (poly(I:C)), a ligand of toll-like receptor-3 (TLR-3). The plant-derived anti-inflammatory agents, dipotassium glycyrrhizinate (GK2) and allantoin, had no influence on the IL-8 expression. The purified compounds, strictinin and casuarictin, inhibited the IL-8 mRNA expression and IL-8 release induced in NHEKs by poly(I:C). These ellagitannins were thus found to be responsible for the biological activity exhibited by the RRFE. This study demonstrates that RRFE and isolated RRFE compounds show promise as ingredients for products formulated to improve skin disorders induced by UVR irradiation.

Entities:  

Keywords:  Anti-inflammatory effects; Casuarictin; IL-8; Rosa roxburghii; Strictinin; TLR-3

Year:  2021        PMID: 33830449     DOI: 10.1007/s11418-021-01509-x

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  37 in total

Review 1.  Ultraviolet light induced injury: immunological and inflammatory effects.

Authors:  G J Clydesdale; G W Dandie; H K Muller
Journal:  Immunol Cell Biol       Date:  2001-12       Impact factor: 5.126

2.  Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin.

Authors:  A Ouhtit; H K Muller; D W Davis; S E Ullrich; D McConkey; H N Ananthaswamy
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 3.  Skin aging and photoaging: an overview.

Authors:  B A Gilchrest
Journal:  J Am Acad Dermatol       Date:  1989-09       Impact factor: 11.527

4.  The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes.

Authors:  J C Ansel; T A Luger; I Green
Journal:  J Invest Dermatol       Date:  1983-12       Impact factor: 8.551

5.  Ultraviolet light induces increased circulating interleukin-6 in humans.

Authors:  A Urbanski; T Schwarz; P Neuner; J Krutmann; R Kirnbauer; A Köck; T A Luger
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

6.  Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury.

Authors:  K D Cooper; N Duraiswamy; C Hammerberg; E Allen; C Kimbrough-Green; W Dillon; D Thomas
Journal:  J Invest Dermatol       Date:  1993-08       Impact factor: 8.551

7.  IL-8 gene expression and production in human keratinocytes and their modulation by UVB.

Authors:  S Kondo; T Kono; D N Sauder; R C McKenzie
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

8.  Properties of murine and human epidermal cell-derived thymocyte-activating factor.

Authors:  T A Luger; M B Sztein; J A Schmidt; P Murphy; G Grabner; J J Oppenheim
Journal:  Fed Proc       Date:  1983-07

9.  Immunohistological detection of interleukin I-like molecules and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivo.

Authors:  A Oxholm; P Oxholm; B Staberg; K Bendtzen
Journal:  Br J Dermatol       Date:  1988-03       Impact factor: 9.302

10.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

Authors:  A Köck; T Schwarz; R Kirnbauer; A Urbanski; P Perry; J C Ansel; T A Luger
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.